Karo Pharma has offered 35 nok a share for Weifa. This leaves me with about 30% gain not counting dividends. But I am somewhat disappointed, I figured Weifa would do great on their own. But hey – this is capitalism. I’ll take the money and move on.
Apparently my sale of Wilhelmsen was premature. Since my sale, the share has risen to near ath. Still, I believe the decision was right. Looking at the last report, the competition is difficult for WWL, and they are loosing money. On top of that, the high and heavy segment has not returned. Still, the share… Continue reading WWL
valueinvestor 